2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 23; no. 10; pp. 1612 - 1676
Main Authors Steffel, Jan, Collins, Ronan, Antz, Matthias, Cornu, Pieter, Desteghe, Lien, Haeusler, Karl Georg, Oldgren, Jonas, Reinecke, Holger, Roldan-Schilling, Vanessa, Rowell, Nigel, Sinnaeve, Peter, Vanassche, Thomas, Potpara, Tatjana, Camm, A John, Heidbüchel, Hein
Format Journal Article
LanguageEnglish
Published England Oxford University Press 09.10.2021
Subjects
Administration, Oral
Anticoagulants - adverse effects
apixaban
Atrial Fibrillation - complications
Atrial Fibrillation - diagnosis
Atrial Fibrillation - drug therapy
dabigatran
Dabigatran - therapeutic use
DOACs
edoxaban
EHRA Practical Guide
Humans
NOACs
Official Statement
Pyridones - therapeutic use
rivaroxaban
Rivaroxaban - therapeutic use
Stroke - diagnosis
Stroke - etiology
Stroke - prevention & control
NOACs
dabigatran
rivaroxaban
DOACs
apixaban
edoxaban
Online AccessGet full text
ISSN1099-5129
1532-2092
1532-2092
DOI10.1093/europace/euab065

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1099-5129
1532-2092
1532-2092
DOI:10.1093/europace/euab065